U.S. Marketing Rights to Mondoxyne Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
U.S. Marketing Rights to Mondoxyne General Information
Description
The marketing rights of an oral antibiotic. The oral antibiotic is used in case of severe acne.
Contact Information
Corporate Office
- United States
Corporate Office
- United States
U.S. Marketing Rights to Mondoxyne Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
U.S. Marketing Rights to Mondoxyne FAQs
-
Where is U.S. Marketing Rights to Mondoxyne headquartered?
U.S. Marketing Rights to Mondoxyne is headquartered in .
-
What industry is U.S. Marketing Rights to Mondoxyne in?
U.S. Marketing Rights to Mondoxyne’s primary industry is Buildings and Property.
-
Is U.S. Marketing Rights to Mondoxyne a private or public company?
U.S. Marketing Rights to Mondoxyne is a Private company.
-
What is U.S. Marketing Rights to Mondoxyne’s current revenue?
The current revenue for U.S. Marketing Rights to Mondoxyne is .
-
When was U.S. Marketing Rights to Mondoxyne acquired?
U.S. Marketing Rights to Mondoxyne was acquired on 01-Jan-2015.
-
Who acquired U.S. Marketing Rights to Mondoxyne?
U.S. Marketing Rights to Mondoxyne was acquired by Sonoma Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process